Literature DB >> 11571355

Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI.

M Bozzali1, M Franceschi, A Falini, S Pontesilli, M Cercignani, G Magnani, G Scotti, G Comi, M Filippi.   

Abstract

The authors measured mean diffusivity (D) and magnetization transfer ratio (MTR) of the brain from 18 patients with AD and 16 healthy control subjects. The peak heights of cortical gray matter (cGM) D (p < 0.001) and MTR (p < 0.001) histograms were lower and average cGM D (p < 0.01) higher in patients with AD than in control subjects. A composite MR score based on brain volume and cGM MTR peak height was correlated with patient cognitive impairment (r = 0.65, p = 0.003). This preliminary study presents a novel approach to quantify AD-related tissue damage in-vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11571355     DOI: 10.1212/wnl.57.6.1135

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

Review 1.  MR diffusion tensor imaging: a window into white matter integrity of the working brain.

Authors:  Sandra Chanraud; Natalie Zahr; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychol Rev       Date:  2010-04-27       Impact factor: 7.444

2.  Brain-water diffusion coefficients reflect the severity of inherited prion disease.

Authors:  H Hyare; S Wroe; D Siddique; T Webb; N C Fox; J Stevens; J Collinge; T Yousry; J S Thornton
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

Review 3.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment.

Authors:  M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

Review 5.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

6.  Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Authors:  Y Likitjaroen; T Meindl; U Friese; M Wagner; K Buerger; H Hampel; S J Teipel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-08-05       Impact factor: 5.270

7.  Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study.

Authors:  Hyun Cho; Dong Won Yang; Young Min Shon; Beum Saeng Kim; Yeong In Kim; Young Bin Choi; Kwang Soo Lee; Yong Soo Shim; Bora Yoon; Woojin Kim; Kook Jin Ahn
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

8.  Diffusion anisotropy and diffusivity of white matter tracts within the temporal stem in Alzheimer disease: evaluation of the "tract of interest" by diffusion tensor tractography.

Authors:  T Taoka; S Iwasaki; M Sakamoto; H Nakagawa; A Fukusumi; K Myochin; S Hirohashi; T Hoshida; K Kichikawa
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

9.  White Matter Integrity and Episodic Memory Performance in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study.

Authors:  Felicia C Goldstein; Hui Mao; Liya Wang; Chunchun Ni; James J Lah; Allan I Levey
Journal:  Brain Imaging Behav       Date:  2009-06       Impact factor: 3.978

10.  CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.

Authors:  Charles B Stevenson; Moneeb Ehtesham; Kathryn M McMillan; J Gerardo Valadez; Michael L Edgeworth; Ronald R Price; Ty W Abel; Khubaib Y Mapara; Reid C Thompson
Journal:  Neurosurgery       Date:  2008-09       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.